INTRODUCTION
varicella-zoster, hepatitis B, anthrax, coronavirus disease 2019
ANTHRAX, CORONAVIRUS DISEASE 2019, VACCINIA, CORONAVIRUS, SEVERE ACUTE RESPIRATORY SYNDROME
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that emerged in December 2019 resulting in the coronavirus disease 2019 (COVID-19) pandemic. Several authorized monoclonal antibody (MAb) cocktails have demonstrated reduced efficacy against certain emerging SARS-CoV-2 variants (This study evaluated the safety and pharmacokinetics (PK) of three COVID-HIGIV dose levels administered intravenously as a single dose to healthy adults. COVID-HIGIV is similar to other human immunoglobulin intravenous (IGIV) products indicated for varicella-zoster, hepatitis B, anthrax, or vaccinia (